.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In September 2026, NectarBee concentrated 59.0% of sales in Concentrates while Topical held 37.6%, with Beverage at 3.35%, indicating a narrowed portfolio as Concentrates fell 43.5% MoM and 24.2% YoY and Topical contracted 77.9% MoM and 73.2% YoY. Beverage softened by 33.5% MoM and 26.6% YoY, while the brand’s average price declined 17.6% YoY against a brand-level sales drop of 55.1% YoY, implying price cuts did not offset volume compression. The thesis is that category exposure amplified the downturn: outsized dependence on Topical and Concentrates during steep MoM and YoY declines concentrated risk rather than cushioning it.
These shifts reposition NectarBee toward a leaner, Concentrates-led mix with reduced diversification, as the 21.4 percentage-point gap between Concentrates share (59.0%) and Topical share (37.6%) widened under sharper Topical declines of 73.2% YoY versus 24.2% YoY in Concentrates. The absence of a category where share or growth offset losses, alongside a 33.5% MoM drop in Beverage despite a lower $6.58 average price, suggests the brand is not leveraging value-entry formats to stabilize traffic, and that reliance on Colorado Concentrates without an anchor rank presents limited defensive positioning when category headwinds intensify.
Competitive Landscape
NectarBee sits at rank #67 in Colorado Concentrates in September 2026, a 3-place improvement from #70 year over year, but down 13 positions from its July 2026 peak at #54; by contrast, 710 Labs moved from #2 to #1 while posting a -18.7% year-over-year sales change, and Sunshine Extracts climbed from #6 to #2 with a 49.9% increase, indicating NectarBee’s modest rank gain is occurring amid faster top-end reshuffling. Given the 3-rank YoY improvement but a 13-rank slide since July 2026, the trajectory implies mid-quarter volatility that risks further share erosion if momentum does not stabilize.
Notable Products
CBD/THC 1:5 Heal Line Nerve Salve (50mg CBD, 250mg THC, 1.78oz) posted the steepest decline at -87.1% MoM and slid to rank 3, while Pure Caviar (1g) fell -43.5% MoM yet held rank 1. CBD/THC 1:1 Heal Line Muscle Balm (100mg CBD, 100mg THC) dropped -62.7% MoM at rank 2, and Ginger Ale (10mg, 355ml) declined -33.6% MoM at rank 4, concentrating three of the top four ranks in non-flower wellness formats. With Topical SKUs occupying ranks 2 and 3 despite double-digit contractions and Concentrates anchoring rank 1 amid a sharp pullback, the pattern implies overexposure to therapeutic niches with high volatility rather than steady, basket-building edibles.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
